### Key Metrics Analysis
Revenue Performance
- Total Revenue: $1.4 billion, up 4% YoY
- Organic Growth Rate: 8%, excluding CSL and Whole Blood impacts
- Q4 Revenue trend shows a positive quarterly growth rate, enhancing the overall fiscal year outlook.
Profitability Metrics
- Gross Profit: $193 million (Gross Margin: 60.2%), reflecting a YoY increase of 620 basis points.
- Operating Income: $82.3 million, with a 24.9% Operating Margin, up 610 basis points YoY.
- Net Income for the quarter is reported at $58 million, translating to an EPS of $1.17, up 192.5% YoY.
Cash Flow and Balance Sheet Health
- Free Cash Flow: $145 million, signifying a conversion ratio of 63% of adjusted net income.
- Cash at period end: $307 million with a net leverage ratio of approximately 2.52x EBITDA, indicating firm liquidity and financial flexibility.